A trial will assess whether the vaccine produces a strong immune response in six to 17-year-olds.
READ SOURCE
A trial will assess whether the vaccine produces a strong immune response in six to 17-year-olds.
READ SOURCE
This website uses cookies. By continuing to use this site, you accept our use of cookies.